BTIG Research reaffirmed their buy rating on shares of Tiziana Life Sciences ( NASDAQ:TLSA – Free Report ) in a report released on Tuesday,Benzinga reports.
Several other equities analysts also recently weighed in on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Tiziana Life Sciences in a research report on Wednesday, August 26th. Zacks Research upgraded Tiziana Life Sciences to a “hold” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Tiziana Life Sciences presently has an average rating of “Hold”.
Get Tiziana Life Sciences alerts: Read Our Latest Research Report on Tiziana Life Sciences
Tiziana Life Sciences Stock Performance
Shares of TLSA stock opened at $1.04 on Tuesday. Tiziana Life Sciences has a 1 year low of $0.76 and a 1 year high of $2.35. The stock’s 50 day simple moving average is $1.00 and its two-hundred day simple moving average is $1.19. Insider Activity In related news, CEO Ivor Elrifi bought 237,616 shares of the stock in a transaction dated Wednesday, August 5th. The ...